Campbell; Simon Fraser

Patent Applications and Registrations

Patent applications and USPTO patent grants for Campbell; Simon Fraser.The latest application filed is for "heterocyclic compounds and uses thereof".

Company Profile

1.10.12

Campbell; Simon Fraser - Poole GB
Campbell; Simon Fraser - Deal GB
Campbell; Simon Fraser - Kent GB
Campbell, Simon Fraser - Sandwich GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heterocyclic Compounds and Uses Thereof App 20190350906 - Ren; Pingda ; et al.	2019-11-21
Heterocyclic Compounds and Uses Thereof App 20180042902 - Ren; Pingda ; et al.	2018-02-15
Substituted benzimidazoles as PI3 kinase inhibitors Grant 9,359,352 - Ren , et al. June 7, 2	2016-06-07
Heterocyclic Compounds And Uses Thereof App 20150320727 - Ren; Pingda ; et al.	2015-11-12
Heterocyclic Compounds and Uses Thereof App 20150322064 - Ren; Pingda ; et al.	2015-11-12
Heterocyclic compounds and uses thereof Grant 9,127,000 - Ren , et al. September 8, 2	2015-09-08
Substituted benzoxazoles as PI3 kinase inhibitors Grant 9,096,590 - Ren , et al. August 4, 2	2015-08-04
Heterocyclic compounds and uses thereof Grant 9,085,560 - Ren , et al. July 21, 2	2015-07-21
Heterocyclic Compounds And Uses Thereof App 20150158859 - Ren; Pingda ; et al.	2015-06-11
Heterocyclic Compounds And Uses Thereof App 20130261102 - Ren; Pingda ; et al.	2013-10-03
Heterocyclic Compounds And Uses Thereof App 20130035324 - Ren; Pingda ; et al.	2013-02-07
cGMP-PDE inhibitors for the treatment of erectile dysfunction App 20040087599 - Campbell, Simon Fraser ; et al.	2004-05-06
6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-one cGMP-PDE inhibitors for the treatment of erectile dysfunction Grant 6,656,945 - Campbell , et al. December 2, 2	2003-12-02
6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-one cGMP-PDE inhibitors for the treatment of erectile dysfunction App 20010044441 - Campbell, Simon Fraser ; et al.	2001-11-22
4-aminoquinazoline derivative cGMP-PDE inhibitors for the treatment of erectile dysfunction Grant 6,300,335 - Campbell , et al. October 9, 2	2001-10-09
Bicyclic heterocyclic compounds for the treatment of impotence Grant 6,100,270 - Campbell August 8, 2	2000-08-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.